NP591 significantly reduced tumor growth in the RD, but not in the OVCAR-5 model, likely reflecting the potent antitumor activity of EpCAM CAR-T cells in this experiment, which could only be marginally enhanced by NP591 (Fig. 7, B and F). The gene discussed is EPCAM; the disease is neoplasm.